Distinct clinicopathological features of ovarian endometriosis after long-term exposure to mifepristone
article
OA: gold
CC0
Abstract
OBJECTIVE: Mifepristone has been used to treat endometriosis, but it can cause a constellation of endometrial alterations. Our study investigated the effects of long-term mifepristone on ovarian endometriosis.
METHODS: We retrospectively analyzed the clinicopathological changes of ovarian endometriosis in 11 Chinese patients after long-term low-dose mifepristone therapy and compared these alterations with those observed in eutopic endometrium and adenomyosis side-by-side. Immunohistochemistry was applied to investigate estrogen receptor (ER), progesterone receptor (PR), and Ki67 expression in eutopic and ectopic endometrium.
RESULTS: Nearly all patients had a pelvic mass and elevated serum CA125 levels. The ovarian lesions were grossly solid, cystic-solid, or cystic. They had a grayish-reddish appearance and a fleshy, honeycomb-like cut surface. The ovarian lesions shared morphological features with the uterine endometrium, and they were characterized by dilated, crowding endometrial glands with non-physiological changes. Immunostaining revealed consistent staining for ER and PR and a low Ki67 index in both eutopic and ectopic endometrium.
CONCLUSIONS: Our findings suggest that ovarian endometriosis can mimic an endometrioid borderline tumor after long-term mifepristone administration. Careful histological assessment and related clinical information are critical for the correct interpretation of these rare entities.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (21)
- Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids via openalex
- Daily Low-Dose Mifepristone Has Contraceptive Potential by Suppressing Ovulation and Menstruation: A Double-Blind Randomized Control Trial of 2 and 5 mg per Day for 120 Days via openalex
- Effect of long-term treatment with low-dose mifepristone on the endometrium via openalex
- Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator via openalex
- Endometriosis and infertility: pathophysiology and management via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Genomic Alterations in Ectopic and Eutopic Endometria of Women with Endometriosis via openalex
- Polypoid Endometriosis via openalex
- Use of Mifepristone to Treat Endometriosis: A Review of Clinical Trials and Trial-Like Studies Conducted in China via openalex
- W2336040302 via openalex
- W3022558870 via openalex
- W1969068003 via openalex
- W3081386294 via openalex
- W1982488750 via openalex
- W2026392453 via openalex
- W2033166710 via openalex
- W2059796825 via openalex
- W2090747009 via openalex
- W2101278668 via openalex
- W2157162135 via openalex
- W2163946488 via openalex
Source provenance
- europepmc
- last seen: 2026-06-14T06:08:20.186862+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-14T06:07:51.997929+00:00
License: CC0
· commercial use OK